Meanwhile, for low expression of FXYD6 there was higher fraction of B cells naïve, CD8 T cells, and macrophages M1, yet less NK cells resting, and monocytes in gliomas (p < 0.05) (Figure S3A). This evidence concerns the gene FXYD6 and central nervous system cancer.